Atopic Dermatitis Adherence Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02169986|
Recruitment Status : Unknown
Verified June 2014 by University of British Columbia.
Recruitment status was: Not yet recruiting
First Posted : June 23, 2014
Last Update Posted : June 23, 2014
|Condition or disease||Intervention/treatment||Phase|
|Atopic Dermatitis/Eczema||Behavioral: electronic reminders||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Family Practice Resident Research Project: Do Electronic Reminders Increase Adherence of Moisturizer Utilization in Paediatric Atopic Dermatitis?|
|Study Start Date :||August 2014|
|Estimated Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||December 2014|
No Intervention: control group
Parents/caregivers will receive the standard of care.
Experimental: electronic reminders
In this group, the parents/caregivers will receive two daily electronic reminders in addition to the standard of care.
Behavioral: electronic reminders
- Adherence [ Time Frame: Effects of electronic reminders on the adherence of 20 parents/caregivers at the end of 28 days study ]The results on adherence of the 20 parents/caregivers in the experimental arm(using electronic reminders) will be contrasted with another 20 parents/caregivers in the control arm.
- EASI score changes [ Time Frame: The EASI score of the patients' eczema will be measured at the beginning and end of the 28 days study ]The differences in the EASI score on both groups can be used as and indirect measurement of the adherence of the parents/caregivers to the treatment.
- Moisturizer [ Time Frame: The use of moisturizer among both groups could be used as an indirect measure of adherence to treatment ]The moisturizer jar will be weighted at the beginning and end of the study. That way the amount of moisturizer will be calculated in grams. Because the body surface of the patients in both groups will be obtained at the beginning of the study, the amount of moisturizer per surface can be estimated. If there are significant differences in the use of moisturizer among both groups per unit of surface, this could be used as an indirect measurement of adherence.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02169986
|Contact: James H Bergman, MDfirstname.lastname@example.org|
|Canada, British Columbia|
|Dr Bergman's Paediatric Dermatologic Clinic|
|Vancouver, British Columbia, Canada, V5Z 1K1|
|Principal Investigator: James H Bergman, MD RCPSC|
|Sub-Investigator: Benedict Yap, MD|
|Sub-Investigator: Pedro P Jara Villarroel, MD|
|Principal Investigator:||James H Bergman, MD||University of British Columbia|